Predicted protein targets (top 10)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | SLC6A2 | P23975 | 1/20 | 0.57 |
| ▸ | SLC5A1 | P13866 | 2/20 | 0.54 |
| ▸ | SLC5A2 | P31639 | 1/20 | 0.54 |
| ▸ | TYR | P14679 | 1/20 | 0.51 |
| ▸ | LGALS8 | O00214 | 3/20 | 0.51 |
| ▸ | NPC1 | O15118 | 1/20 | 0.51 |
| ▸ | RAB9A | P51151 | 1/20 | 0.51 |
| ▸ | LGALS3 | P17931 | 3/20 | 0.46 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.45 |
| ▸ | CYP2D6 | P10635 | 1/20 | 0.45 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL15481400 | 1.00 | SLC6A2 (0.57) | SLC6A2SLC5A1SLC5A2TYRLGALS8 | |
| SCHEMBL27473226 | 0.97 | SLC5A1 (0.55) | SLC6A2SLC5A1SLC5A2TYRLGALS8 | |
| SCHEMBL19731784 | 0.93 | SLC5A1 (0.51) | SLC6A2SLC5A1SLC5A2TYRLGALS8 | |
| SCHEMBL14127626 | 0.89 | SLC6A2 (0.58) | SLC6A2TYRLGALS8LGALS3 | |
| SCHEMBL19731823 | 0.89 | GJB2 (0.47) | SLC6A2SLC5A1SLC5A2NPC1RAB9A | |
| SCHEMBL27491005 | 0.86 | SLC6A2 (0.54) | SLC6A2SLC5A1SLC5A2TYRLGALS8 | |
| SCHEMBL13380951 | 0.86 | LGALS8 (0.53) | SLC6A2SLC5A1SLC5A2LGALS8NPC1 | |
| SCHEMBL27490637 | 0.86 | SLC6A2 (0.54) | SLC6A2SLC5A1SLC5A2TYRLGALS8 | |
| SCHEMBL6947007 | 0.86 | LGALS8 (0.53) | SLC6A2SLC5A1SLC5A2LGALS8NPC1 | |
| SCHEMBL27492046 | 0.85 | SLC6A2 (0.52) | SLC6A2SLC5A1SLC5A2TYRLGALS8 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-3133058-B1 | MULTIFUNCTIONAL (METH)ACRYLATE MANUFACTURING METHOD | TOAGOSEI CO LTD (JP) | 2019-05-29 | — | — | EP | disclosed |
| US-10035752-B2 | Multifunctional (meth)acrylate manufacturing method | TOAGOSEI CO., LTD. (JP) | 2018-07-31 | — | — | US | disclosed |
| US-20170204044-A1 | MULTIFUNCTIONAL (METH)ACRYLATE MANUFACTURING METHOD | TOAGOSEI CO., LTD. (JP) | 2017-07-20 | — | — | US | disclosed |
| EP-3133058-A1 | MULTIFUNCTIONAL (METH)ACRYLATE MANUFACTURING METHOD | Toagosei Co., Ltd. (JP) | 2017-02-22 | — | — | EP | disclosed |
| CN-106029628-A | Multifunctional (meth)acrylate manufacturing method | 东亚合成株式会社 | 2016-10-12 | — | — | CN | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-10035752-B2 | Multifunctional (meth)acrylate manufacturing method | MMAB, AMD1, ADH5 | SLC6A2 4737/4885SLC5A1 4540/4885SLC5A2 4670/4885 |
| US-20170204044-A1 | MULTIFUNCTIONAL (METH)ACRYLATE MANUFACTURING METHOD | MMAB, AMD1, ADH5 | SLC6A2 4737/4885SLC5A1 4540/4885SLC5A2 4670/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.